Common Contracts
6 similar Security Agreement contracts by Adaptin Bio, Inc.
FORM OF COMMON STOCK PURCHASE WARRANT ADAPTIN BIO, INC.Security Agreement • August 28th, 2026 • Adaptin Bio, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________________________________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined below) and on or prior to the close of business on the first (1st) anniversary of the final Closing of the Offering (the “Initial Termination Date”), provided that if on the Initial Termination Date or any Extended Termination Date (as defined below) the Common Stock is not admitted for trading or listed on an Approved Market, then the term of exercise of this Warrant shall be extended or further extended to the date that is six (6) months after such Initial Termination Date or Extended Termination Date, as the case may be (each such six- (6-) month extension date an “Extended Termination Date,” and the latest to occur of the Initial Termination Date or the last E
FORM OF COMMON STOCK PURCHASE WARRANT ADAPTIN BIO, INC.Security Agreement • August 28th, 2026 • Adaptin Bio, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________________________________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined below) and on or prior to the close of business on the fifth (5th) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adaptin Bio, Inc., formerly known as Centaur Bio Inc., a Delaware corporation, or its Parent (as defined in the Notes issued to the initial Holder of this Warrant under the Note Exchange Agreement (the “Notes”) (collectively, the “Company”), up to a number shares of Common Stock (the “Warrant Shares”) equal to fifty percent (50%) of the number of shares of Common Stock ( or of the number of shares of Common Stock issuable upon exercise or conversion of Common Stock Equivalents sold in the
FORM OF COMMON STOCK PURCHASE WARRANT ADAPTIN BIO, INC.Security Agreement • August 28th, 2026 • Adaptin Bio, Inc. • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Laidlaw & Company (UK) Ltd. (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined below) and on or prior to the close of business on the seventh (7th) anniversary of the final Closing of the Offering (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adaptin Bio, Inc. (formerly known as Unite Acquisition 1 Corp.), a Delaware corporation (the “Company”), up to _______________________________________ (__________) shares of Common Stock (the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
FORM OF COMMON STOCK PURCHASE WARRANT ADAPTIN BIO, INC.Security Agreement • August 28th, 2026 • Adaptin Bio, Inc. • Biological products, (no disgnostic substances) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined below) and on or prior to the close of business on the fifth (5th) anniversary of the final Closing of the Offering (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adaptin Bio, Inc., a Delaware corporation (the “Company”), up to ________________ (_________) shares of Common Stock (the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
FORM OF COMMON STOCK PURCHASE WARRANT ADAPTIN BIO, INC.Security Agreement • August 28th, 2026 • Adaptin Bio, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________________________________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined below) and on or prior to the close of business on the fifth (5th) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adaptin Bio, Inc., formerly known as Centaur Bio Inc., a Delaware corporation, or its Parent (as defined in the the Notes issued to the initial Holder of this Warrant under the Note Exchange Agreement (the “Notes”)) (collectively, the “Company”), up to a number shares of Common Stock (the “Warrant Shares”) equal to fifty percent (50%) of the number of shares of Common Stock (or of the number of shares of Common Stock issuable upon exercise or conversion of Common Stock Equivalents sold in
FORM OF COMMON STOCK PURCHASE WARRANT ADAPTIN BIO, INC.Security Agreement • August 28th, 2026 • Adaptin Bio, Inc. • Biological products, (no disgnostic substances)
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________________________________________________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined below) and on or prior to the close of business on the fifth (5th) anniversary of the final Closing of the Offering (the “Termination Date”) but not thereafter, to subscribe for and purchase from Adaptin Bio, Inc. (formerly known as Unite Acquisition 1 Corp.), a Delaware corporation (the “Company”), up to _______________________________________ (__________) shares of Common Stock (the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).